First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells

被引:36
作者
Hojjat-Farsangi, M. [1 ,2 ]
Daneshmanesh, A. H. [1 ,2 ]
Khan, A. S. [1 ,2 ]
Shetye, J. [1 ,2 ]
Mozaffari, F. [1 ,2 ]
Kharaziha, P. [1 ,2 ]
Rathje, L-S [1 ,2 ,3 ]
Kokhaei, P. [1 ,2 ,4 ,5 ]
Hansson, L. [1 ,2 ,6 ]
Vagberg, J. [3 ]
Bystrom, S. [3 ]
Olsson, E. [3 ]
Lofberg, C. [3 ]
Norstrom, C. [3 ]
Schultz, J. [3 ]
Norin, M. [3 ]
Olin, T. [3 ]
Osterborg, A. [1 ,2 ,6 ]
Mellstedt, H. [1 ,2 ]
Moshfegh, A. [1 ,2 ,3 ]
机构
[1] Karolinska Univ Hosp Solna, CCK, Dept Oncol Pathol, Immune & Gene Therapy Lab, Stockholm, Sweden
[2] Karolinska Inst, Stockholm, Sweden
[3] Kancera AB, Solna, Sweden
[4] Semnan Univ Med Sci, Canc Res Ctr, Semnan, Iran
[5] Semnan Univ Med Sci, Dept Immunol, Semnan, Iran
[6] Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
D O I
10.1038/s41375-018-0113-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:2291 / 2295
页数:5
相关论文
共 14 条
  • [1] Identification of Noncanonical Wnt Receptors Required for Wnt-3a-Induced Early Differentiation of Human Neural Stem Cells
    Bengoa-Vergniory, Nora
    Gorrono-Etxebarria, Irantzu
    Lopez-Sanchez, Inmaculada
    Marra, Michele
    Di Chiaro, Pierluigi
    Kypta, Robert
    [J]. MOLECULAR NEUROBIOLOGY, 2017, 54 (08) : 6213 - 6224
  • [2] Structure and regulation of Src family kinases
    Boggon, TJ
    Eck, MJ
    [J]. ONCOGENE, 2004, 23 (48) : 7918 - 7927
  • [3] Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells
    Choudhury, Aniruddha
    Derkow, Katja
    Daneshmanesh, Amir Hossein
    Mikaelsson, Eva
    Kiaii, Shahryar
    Kokhaei, Parviz
    Osterborg, Anders
    Mellstedt, Hakan
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (04) : 327 - 335
  • [4] Modeling the chronic lymphocytic leukemia microenvironment in vitro
    Crassini, Kyle
    Shen, Yandong
    Mulligan, Stephen
    Best, O. Giles
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (02) : 266 - 279
  • [5] Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells
    Daneshmanesh, A. H.
    Hojjat-Farsangi, M.
    Khan, A. S.
    Jeddi-Tehrani, M.
    Akhondi, M. M.
    Bayat, A. A.
    Ghods, R.
    Mahmoudi, A-R
    Hadavi, R.
    Osterborg, A.
    Shokri, F.
    Rabbani, H.
    Mellstedt, H.
    [J]. LEUKEMIA, 2012, 26 (06) : 1348 - 1355
  • [6] Novel Agents in the Treatment of Chronic Lymphocytic Leukemia: A Review About the Future
    Desai, Anjali Varma
    El-Bakkar, Hassan
    Abdul-Hay, Maher
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (06) : 314 - 322
  • [7] Gohil S, 2017, LANCET, V389, P40
  • [8] Gopalakrishnan R, 2017, BLOOD, V130
  • [9] The receptor tyrosine kinase ROR1-An oncofetal antigen for targeted cancer therapy
    Hojjat-Farsangi, Mohammad
    Moshfegh, Ali
    Daneshmanesh, Amir Hossein
    Khan, Abdul Salam
    Mikaelsson, Eva
    Osterborg, Anders
    Mellstedt, Hakan
    [J]. SEMINARS IN CANCER BIOLOGY, 2014, 29 : 21 - 31
  • [10] The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
    Hojjat-Farsangi, Mohammad
    Khan, Abdul Salam
    Daneshmanesh, Amir Hossein
    Moshfegh, Ali
    Sandin, Asa
    Mansouri, Ladan
    Palma, Marzia
    Lundin, Jeanette
    Osterborg, Anders
    Mellstedt, Hakan
    [J]. PLOS ONE, 2013, 8 (10):